Efficacy of doxycycline in the treatment of early stages of mycosis fungoides: a randomized controlled trial

References

• Sors A, Jean-Louis F, Pellet C, et al. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Blood. 2006;107(6):2354–2363.
   PubMed Web of Science ®Google Scholar
• Oeckinghaus A, Ghosh S. The NF-kappa B family of transcription factors and its regulation. Cold Spring Harb Perspect Boil. 2009;1:1–14.
   Web of Science ®Google Scholar
• Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 2009;1(5):a000141.
   PubMed Web of Science ®Google Scholar
• Knadolf Sekulovic L, Cikota B, Jovic M, et al. The role of apoptosis and cell-proliferation regulating genes in mycosis fungoides. J Dermatol Sci. 2009;55:53–56.
   PubMed Web of Science ®Google Scholar
• Willemze R, Jaffe E, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–3785.
   PubMed Web of Science ®Google Scholar
• Kim Y, Martinez G, Varghese A, et al. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience. Arch Dermatol. 2003;139(2):165–173.
   PubMedGoogle Scholar
• Jawed S, Myskowski P, Horwitz S, et al. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): Part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014;70(2):223.e1–223.e17.
   Web of Science ®Google Scholar
• Hoot J, Wang L, Kho T, et al. The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides. J Dermatolog Treat. 2018;29(3):272–276.
   PubMed Web of Science ®Google Scholar
• Prichard M, Harris T, Williams M, et al. Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma. Expert Opin Pharmacother. 2009;10(6):983–995.
   PubMed Web of Science ®Google Scholar
• Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther. 2005;27(9):1329–1342.
   PubMed Web of Science ®Google Scholar
• Pirard B. Insight into the structural determinants for selective inhibition of matrix metalloproteinases. Drug Discov Today. 2007;12(15–16):640–646.
   PubMed Web of Science ®Google Scholar
• Henehan M, Montuno M, De Benedetto A. Doxycycline as an anti-inflammatory agent: updates in dermatology. J Eur Acad Dermatol Venereol. 2017;31(11):1800–1808.
   PubMed Web of Science ®Google Scholar
• Lokeshwar BL, Selzer MG, Zhu BQ, et al. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int J Cancer. 2002;98(2):297–309.
   PubMed Web of Science ®Google Scholar
• Pulvino M, Chen L, Oleksyn D, et al. Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline. Oncotarget. 2015;6(17):14796–14813.
   PubMedGoogle Scholar
• Kao GD, Jiang Z, Fernandes AM, et al. Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation. J Biol Chem. 2007;282(29):21206–21212.
   PubMed Web of Science ®Google Scholar
• Son K, Fujioka S, Iida T, et al. Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells. Anticancer Res. 2009;29(10):3995–4003.
   PubMed Web of Science ®Google Scholar
• Holmes N, Charles P. Safety and efficacy review of doxycycline. Clin Med Insights Ther. 2009;1:471–482.
   Google Scholar
• Neckers L, Workman P. Hsp90 molecular chaperone inhibitors: are we there yet? Clin Cancer Res. 2012;18(1):64–76.
   PubMed Web of Science ®Google Scholar
• Wu Z, Gholami AM, Kuster B. Systemic identification of the HSP90 candidate regulated proteome. Mol Cell Proteomics. 2012;11(6):M111.016675.
   PubMed Web of Science ®Google Scholar
• Husain FM, Ahmad I. Doxycycline interferes with quorum sensing-mediated virulence factors and biofilm formation in Gram negative bacteria. World J Microbiol Biotechnol. 2013;29(6):949–957.
   PubMed Web of Science ®Google Scholar
• Song H, Fares M, Maguire K, et al. Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells. PLoS One. 2014;9(12):e114457.
   PubMed Web of Science ®Google Scholar
• Yang B, Lu Y, Zhang A, et al. Doxycycline induces apoptosis and inhibits proliferation and invasion of human cervical carcinoma stem cells. PLoS One. 2015;10(6):e0129138.
   PubMed Web of Science ®Google Scholar
• Galván-Salazar H, Soriano-Hernández A, Montes-Galindo D, et al. Preclinical trial on the use of doxycycline for the treatment of adenocarcinoma of the duodenum. Mol Clin Oncol. 2016;5(5):657–659.
   PubMed Web of Science ®Google Scholar
• Kashii-Magaribuchi K, Takeuchi R, Haisa Y, et al. Induced expression of cancer stem cell markers ALDH1A3 and Sox-2 in hierarchical reconstitution of apoptosis-resistant human breast cancer cells. Acta Histochem Cytochem. 2016;49(5):149–158.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhao B, Liu Y, et al. New application of an old drug: antitumor activity and mechanisms of doxycycline in small cell lung cancer. Int J Oncol. 2016;48(4):1353–1360.
   PubMed Web of Science ®Google Scholar
• Alexander-Savino CV, Hayden M, Richardson C, et al. Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells. Oncotarget. 2016;7(46):75954–75967.
   PubMedGoogle Scholar
• Hume KR, Sylvester SR, Borlle L, et al. Metabolic abnormalities detected in phase II evaluation of doxycycline in dogs with multicentric B-cell lymphoma. Front Vet Sci. 2018;5:25.
   PubMed Web of Science ®Google Scholar
• Toberer F, Hartschuh W, Hadaschik E. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline. JAMA Dermatol. 2013;149(8):956–959.
   PubMed Web of Science ®Google Scholar
• Han JJ, Kim TM, Jeon YK, et al. Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma. Ann Hematol. 2015;94(4):575–581.
   PubMed Web of Science ®Google Scholar
• Hettiaratchy S, Papini R. Initial management of a major burn: II—assessment and resuscitation. BMJ. 2004;329(7457):101–103.
   PubMedGoogle Scholar
• Olsen E, Whittaker S, Kim Y, et al. International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29:2598–2607.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216.
   PubMed Web of Science ®Google Scholar
• Fischer A, Jacobson K, Rose J, et al. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. 2008;2008:pdb.prot4986.
   Google Scholar
• Guitart J, Kennedy J, Ronan S, et al. Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting. J Cutan Pathol. 2001;28(4):174–183.
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York (NY): Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Chan Y. Biostatistics102: quantitative data—parametric & non-parametric tests. Singapore Med J. 2003;44(8):391–396.
   PubMedGoogle Scholar
• Chan Y. Biostatistics 103: qualitative data—tests of independence. Singapore Med J. 2003;44(10):498–503.
   PubMedGoogle Scholar
• Chan Y. Biostatistics 104: correlational analysis. Singapore Med J. 2003;44(12):614–619.
   PubMedGoogle Scholar
• Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726–732.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011], The Cochrane Collaboration; 2011. Available from: www.cochrane-handbook.org.
   Google Scholar
• Bosseila M, Sayed Sayed K, El-Din Sayed SS, et al. Evaluation of angiogenesis in early mycosis fungoides patients: dermoscopic and immunohistochemical study. Dermatology (Basel). 2015;231(1):82–86.
   PubMed Web of Science ®Google Scholar
• Nissinen L, Kähäri VM. Matrix metalloproteinases in inflammation. Biochim Biophys Acta. 2014;1840(8):2571–2580.
   PubMed Web of Science ®Google Scholar
• Rasheed H, Tolba Fawzi MM, Abdel-Halim MR, et al. Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides. Am J Dermatopathol. 2010;32(2):162–169.
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Ria R, et al. Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression. Dev Immunol. 2000;7(2–4):77–88.
   PubMedGoogle Scholar
• Gettler S, Fung M. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses. Dermatol Online J. 2005;11(3):6.
   PubMedGoogle Scholar
• Herrman JJ, Roenigk HH, Jr, Hurria A, et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol. 1995;3:234–242.
   Google Scholar
• Papadavid E, Economidou J, Psarra A, et al. The relevance of peripheral blood T-helper 1 and 2 cytokine patterns in the evaluation of patients with mycosis fungoides and Sezary syndrome. Br J Dermatol. 2003;148(4):709–718.
   PubMed Web of Science ®Google Scholar
• Ferrara G, Crisman G, Zalaudek I, et al. Free-floating collagen fibers in interstitial mycosis fungoides. Am J Dermatopathol. 2010;32(4):352–356.
   PubMed Web of Science ®Google Scholar
• Johnson R, Staiano-Coico L, Austin L, et al. PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in human T lymphocytes. Photochem Photobiol. 1996;63(5):566–571.
   PubMed Web of Science ®Google Scholar
• Viola G, Fortunato E, Cecconet L, et al. Central role of mitochondria and P53 in PUVA-induced apoptosis in human keratinocytes cell line nctc-2544. Toxicol Appl Pharmacol. 2008;277:84–96.
   Google Scholar
• Werber-Bandeira L, Herdy AM, Pagani EA, et al. Primary cutaneous T cell lymphomas: photochemotherapy immunomodulation with analysis of the inflammatory-expansive cellular dynamic. Dermatol Ther. 2014;27(2):74–78.
   PubMed Web of Science ®Google Scholar
• Yeh YC, Lai HC, Ting CT, et al. Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol. 2007;74(7):969–980.
   PubMed Web of Science ®Google Scholar
• Scarabelli TM, Stephanou AE, Pasini E, et al. Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. J Am Coll Cardiol. 2004;43(5):865–874.
   PubMed Web of Science ®Google Scholar
• Bienenfeld A, Nagler AR, Orlow SJ. Oral antibacterial therapy for acne vulgaris: an evidence-based review. Am J Clin Dermatol. 2017;18(4):469–490.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390.
   PubMed Web of Science ®Google Scholar